Email bulletins

Archive

February 2019

  • DAA treatment reduces the risk of death and liver cancer in France
  • Experimental therapy improves liver health in people with fatty liver disease
  • Immunotherapy combinations show promise for liver cancer
  • Generic treatment and hepatitis C elimination in Egypt
  • Hepatitis C cure does not improve long-term glucose control
  • Tackling HIV and hepatitis C in Europe: towards minimum standards
  • Improving the uptake of hepatitis C care in people who inject drugs
  • Is this your copy of the infohep news bulletin?

January 2019

  • Lancet Commission recommends actions to support elimination of hepatitis C
  • HCV modelling study
  • HIV/HCV co-infection and end-stage liver disease
  • Survival after liver cancer diagnosis is shorter in people living with HIV
  • Conditional cash transfers to encourage hepatitis C diagnosis and treatment in people who inject drugs
  • Barriers to HCV treatment in people who inject drugs
  • TAF for hepatitis B
  • AbbVie legal challenge in UK tender exercise dismissed
  • Is this your copy of the infohep news bulletin?